Invista, Dasatinib

Invista is used for the treatment of chronic myeloid leukaemia (CML) and acute lymphoblastic leukaemia (ALL).

Invista is known as an anti cancer medicine, Invista is known as a tyrosine kinase inhibitor. Invista works by blocking the chemical messengers (called tyrosine kinases) which send signals to cells to grow. This in turn stops the cancerous cells growing and increasing in number.

Some of the potential side effects of Invista can include the symptoms below;

Breathing difficulty,
Anemia,
Fatigue,
Infection,
Nausea,
Rash,
Headache,
Edema,
Reduced blood platelets,
Musculoskeletal pain,
Vomiting,
Abdominal pain,
Fever,
Bleeding.